David Arterburn to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications David Arterburn has written about Diabetes Mellitus, Type 2.
Connection Strength
3.911
-
Cost and Health Care Utilization Implications of Bariatric Surgery Versus Intensive Lifestyle and Medical Intervention for Type 2 Diabetes. Obesity (Silver Spring). 2017 09; 25(9):1499-1508.
Score: 0.345
-
Long-term Microvascular Disease Outcomes in Patients With Type 2 Diabetes After Bariatric Surgery: Evidence for the Legacy Effect of Surgery. Diabetes Care. 2016 Aug; 39(8):1400-7.
Score: 0.319
-
Bariatric Surgery for Type 2 Diabetes: Getting Closer to the Long-term Goal. JAMA. 2016 Mar 22-29; 315(12):1276-7.
Score: 0.313
-
The geography of diabetes by census tract in a large sample of insured adults in King County, Washington, 2005-2006. Prev Chronic Dis. 2014 Jul 24; 11:E125.
Score: 0.280
-
Gastric bypass surgery is more efficacious than intensive lifestyle and medical treatment for type 2 diabetes remission. Evid Based Med. 2014 Apr; 19(2):e14.
Score: 0.268
-
The authors respond: a multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg. 2013 Sep; 23(9):1456-7.
Score: 0.264
-
Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults. Obes Res Clin Pract. 2013 Jul-Aug; 7(4):e258-68.
Score: 0.261
-
A population-based, shared decision-making approach to recruit for a randomized trial of bariatric surgery versus lifestyle for type 2 diabetes. Surg Obes Relat Dis. 2013 Nov-Dec; 9(6):837-44.
Score: 0.259
-
A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg. 2013 Jan; 23(1):93-102.
Score: 0.252
-
A look ahead at the future of diabetes prevention and treatment. JAMA. 2012 Dec 19; 308(23):2517-8.
Score: 0.251
-
Comparative Safety and Effectiveness of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for Weight Loss and Type 2 Diabetes Across Race and Ethnicity in the PCORnet Bariatric Study Cohort. JAMA Surg. 2022 10 01; 157(10):897-906.
Score: 0.124
-
Comparative effectiveness of gastric bypass and sleeve gastrectomy on predicted 10-year risk of cardiovascular disease 5 years after surgery. Surg Obes Relat Dis. 2022 06; 18(6):716-726.
Score: 0.119
-
Benefits and Risks of Bariatric Surgery in Adults: A Review. JAMA. 2020 09 01; 324(9):879-887.
Score: 0.107
-
Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study. JAMA Surg. 2020 05 01; 155(5):e200087.
Score: 0.105
-
Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach. Diabetes Care. 2020 04; 43(4):852-859.
Score: 0.103
-
Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity. JAMA. 2018 10 16; 320(15):1570-1582.
Score: 0.094
-
Economic Value of Greater Access to Bariatric Procedures for Patients With Severe Obesity and Diabetes. Med Care. 2018 07; 56(7):583-588.
Score: 0.092
-
Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications. Diabetes Care. 2016 Jun; 39(6):912-23.
Score: 0.080
-
Improvements in glycemic control after gastric bypass occur despite persistent adipose tissue inflammation. Obesity (Silver Spring). 2016 07; 24(7):1438-45.
Score: 0.080
-
Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia. 2016 May; 59(5):945-53.
Score: 0.079
-
Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014 Aug 27; 349:g3961.
Score: 0.071
-
Bariatric surgery. BMJ. 2008 Jul 31; 337:a755.
Score: 0.046